Terry Smith slammed two of Denmark’s largest life sciences companies — Novo Nordisk A/S and Coloplast A/S — after they ...

Exploring the Strategic Adjustments in the Fund's Portfolio. Invesco EQV European Equity Fund (Trades, Portfolio) recently ...

Coloplast A/S is acquiring Kerecis hf, a closely held Icelandic maker of fish-skin dressings to treat human wounds, for an enterprise value of up to $1.3 billion.

Coloplast has agreed to buy Iceland-based Kerecis, a biologic wound care firm that uses fish skin to develop tissue-transplant products, for up to $1.3 billion, the Danish medical equipment maker ...

Review the current Coloplast AS ADR (CLPBY:PINX) growth, profitability and efficiency, financial health, and cash flow key metrics to decide if CLPBY is the best investment for you.

Coloplast is absolutely a high-quality med-tech growth story and is worthy of a premium. Unfortunately, even with an advantageous discount rate, the shares are not cheap on discounted cash flow.

Coloplast delivered Q4 organic growth of 8% and an EBIT margin 1 of 26%, which was negatively impacted by extraordinary costs and currencies. Reported revenue in DKK grew 12% with 3%- pts ...

The event will take place on Thursday, 6 June 2024 at Coloplast’s HeadquartersHoltedam 3, 3050 Humlebaek, Denmarkfrom 11.30 - 18.00 CEST (Central European Summer Time) Coloplast invites ...

View the latest Coloplast A/S ADR (CLPBY) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Coloplast delivered 8% organic growth and an EBIT margin 1 of 27% in Q1, in line with expectations. In December 2024, Coloplast divested its Skin Care portfolio to simplify business operations and ...

Coloplast announced it will acquire wound care product company Kerecis for $1.3 billion. The acquisition will give Coloplast an opportunity to “strategically strengthen [its] presence in the advanced ...

Coloplast's ownership structure favors the holders of A shares (mainly the Louis-Hansen founding family), which holds 44% of the equity but retains 68% of the voting power.